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Abstract A new UV filter compound, 4-(2-amino-3-hydroxy-
phenyl)-4-oxobutanoic acid O-diglucoside, has been identified in
human lenses. The structure suggests that it is a further
metabolic product of the second most abundant UV filter
compound, 4-(2-amino-3-hydroxyphenyl)-4-oxobutanoic acid O-
glucoside. Quantification studies on the new compound show that
it decreases towards zero in both the nucleus and cortex as a
function of age. The discovery of this novel disaccharide
completes the identification of the major UV filter compounds
present in the human lens. ß 2001 Published by Elsevier Sci-
ence B.V. on behalf of the Federation of European Biochemical
Societies.
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1. Introduction
The primary role of the human lens is to focus light trans-
mitted by the cornea onto the retina to generate an image.
Generation of this image with maximum optical clarity is de-
pendent on the UV ¢ltering capacity of the lens, which con-
tains compounds that absorb most of the light between 295
and 400 nm [1^3]. These UV ¢lter compounds are thought to
protect the lens and retina from harmful photodamage initi-
ated by UV light and aid visual acuity by reducing chromatic
aberration [2]. Since it has been proposed that UV light is
involved in the development of cataract [4^6], understanding
the types of UV ¢lter compounds present in the lens and their
regional concentrations is clearly important.
In humans, the major product of lens tryptophan metabo-
lism is the UV ¢lter compound 3-hydroxykynurenine gluco-
side (3OHKG) [3,7]. This UV ¢lter spontaneously deaminates
at physiological pH to form a highly reactive K,L-ketoalkene
intermediate [8], capable of undergoing three known reac-
tions. These are reduction to form the second most abundant
UV ¢lter compound 4-(2-amino-3-hydroxyphenyl)-4-oxobuta-
noic acid glucoside (AHBG) [8]; addition to the cysteine res-
idue of glutathione to form glutathionyl-3-hydroxykynurenine
glucoside (GSH-3OHKG) [9] ; and binding to human lens
proteins (crystallins) [10]. In vitro studies have recently shown
that the 3OHKG metabolic precursors kynurenine (Kyn) and
3-hydroxykynurenine (3OHKyn) are also capable of partici-
pating in these types of reactions [11^13].
With aging, human lens proteins undergo numerous
changes including a generalised yellowing of the lens nucleus
and an increase in £uorescence [14^16]. The UV ¢lter com-
pounds have been linked to this normal age-dependent colo-
ration and to crystallin modi¢cation observed with the devel-
opment of senile cataract [10,17^19]. In this paper we describe
the identi¢cation of a novel UV ¢lter compound present in
human lenses.
2. Materials and methods
Human lenses were obtained post-mortem from donor eyes at The
Sydney Eye Hospital Lions Eye Bank (Sydney, Australia). Following
removal, the lenses were placed immediately into sterile plastic screw-
capped vials and kept at 320‡C until analysed. Lenses were dissected
frozen and the protein-free lens extracts were obtained following the
conditions previously described [20].
The high-performance liquid chromatography (HPLC) system con-
sisted of two ICI LC 1150 pumps, a Rheodyne 7125 sample injector
and an ICI SD 2100 variable wavelength UV-Vis detector. Chromato-
grams were recorded using the WinChrom chromatography data sys-
tem (GBC Scienti¢c Equipment, NSW, Australia). Standard curves
and separations were performed on a 250 mmU4.6 mm Varian Mi-
crosorb C18 column using an acetonitrile/H2O gradient in 0.05% (v/v)
tri£uoroacetic acid. The percentage acetonitrile in the gradient was 0%
(5 min), 0^40% (50 min), and 40^0% (5 min). A £ow rate of 0.6 ml/
min was used and the peaks were detected at 365 nm.
Mass spectrometry experiments were conducted on the following
instruments. (I) A VG Quattro mass spectrometer with a hexapole
collision cell (VG Biotech, Altrincham, UK). Samples were dissolved
in 50% aqueous acetonitrile in either 1% formic acid (for positive ion
mass spectrometry) or 1% ammonia (for negative ion mass spectrom-
etry). Argon was used as the collision gas. (II) A Bruker BioApex 47e
Fourier transform ion-cyclotron resonance mass spectrometer
(FTMS) (Bruker Daltonics, Billerica, MA, USA). Samples were dis-
solved in 100% methanol and infused continuously into the electro-
spray source (Analytica of Branford, Branford, CT, USA) at a £ow
rate of 80^100 Wl/h. Nitrogen was used as the collision gas for CAD in
the analyser cell.
UV-visible absorption spectra were recorded on a photodiode array
(PDA) detector in line with a capillary liquid chromatography
(CapLC) system (Waters, NSW, Australia). Fluorescence spectra
were recorded on a Hitachi F-4500 £uorescence spectrometer in phos-
phate bu¡er (pH 7.2, 25 mM).
Cleavage of the O-glycosidic bond of the unknown UV ¢lter com-
pound was performed by incubation of the puri¢ed UV ¢lter com-
pound with: (I) almond L-glucosidase (EC 3.2.1.21, Sigma) (1 mg/ml)
in citrate bu¡er (10 mM, pH 5) for 3 h at 37‡C and (II) 1 M HCl at
100‡C for either 10 min or 1 h.
Linear regression analysis was used to evaluate the relationship
between age and the concentration of the unknown UV ¢lter com-
pound. The two-sample paired t-test was used to determine whether
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the nuclear and cortical data points were distinct. A P value 6 0.01
was considered signi¢cant.
3. Results
The HPLC chromatogram of a 20-year-old human lens ex-
tract, with detection at 365 nm, is shown in Fig. 1. Several
peaks were observed. These corresponded to 3OHKyn (peak
1), 3OHKG (peak 2), Kyn (peak 3), AHBG (peak 4) and a
compound of unknown identity (peak 5), with a retention
time of 37 min. No peak was observed for the GSH-
3OHKG adduct, since this compound results from UV ¢lter
instability, and is generally seen in lenses above 40 years of
age [9,20]. In the present study, we describe the identi¢cation
of the unknown compound (U-37).
To establish whether U-37 was related to the other kynur-
enine-derived UV ¢lters, its absorbance and £uorescence char-
acteristics were determined. Firstly, to ensure that U-37 was
completely resolved from AHBG, the peak corresponding to
U-37 was collected from the analytical HPLC system and
rerun on the CapLC system, with the PDA detector in line.
The UV-visible spectrum, obtained from the PDA detector,
displayed two absorbance maxima at 262 and 361 nm and the
£uorescence spectrum exhibited maximum £uorescence inten-
sity at Ex345 nm/Em455 nm (Fig. 2). These characteristics closely
resembled those of the two major UV ¢lter compounds
(3OHKG: Vmax at 365 and 264 nm, Ex347 nm/Em455 nm ;
AHBG: Vmax at 358 and 262 nm, Ex345 nm/Em455 nm) under
these conditions, which suggested that U-37 has a similar
chromophoric structure.
Mass spectrometric experiments performed on the Quattro
mass spectrometer revealed the molecular mass of U-37. A
protonated molecular ion at m/z 534 was observed in the
positive ion electrospray mass spectrum and a deprotonated
molecular ion at m/z 532 was observed in the negative ion
electrospray mass spectrum. These data indicated a molecular
mass of 533 Da. Further analysis by high-resolution mass
spectrometry revealed a protonated molecular ion at m/z
534.181174, which corresponds to the molecular formula
[C22H32NO14]. The molecular mass of U-37 is 162 Da units
more than that of AHBG, and both the molecular mass and
molecular formula are consistent with a structure consisting of
AHBG plus an additional C-6 sugar unit. Tandem mass spec-
trometry performed in the positive mode displayed daughter
ions at m/z 372 and m/z 210. This fragmentation pattern re-
sults from the sequential loss of 162 Da, which is a character-
istic loss from hexose-containing molecules. Tandem mass
spectrometry of AHBG collected from a human lens displayed
a protonated molecular ion at m/z 372 and a major fragment
at m/z 210. These preliminary data indicated that U-37 could
be a compound related in structure to AHBG. Further mass
spectrometry and hydrolysis data, described below, are con-
sistent with the structure of U-37 as shown in Fig. 3.
High-resolution tandem mass spectrometry experiments
were performed on puri¢ed isolates of U-37 using the Fourier
transform ion-cyclotron resonance mass spectrometer. In the
positive mode, a sodiated parent ion at m/z 556.14 displayed
three intense fragment peaks (Fig. 3A). These corresponded to
loss of the side chain attached to the aromatic ring (fragment
a), loss of a C-6 sugar unit leaving sodiated AHBG (fragment
Fig. 1. HPLC chromatogram of the ethanol extract of a 20-year-old
human lens. UV detection at 365 nm. 1 = 3OHKyn; 2 = 3OHKG;
3 = Kyn; 4 = AHBG; 5 = U-37.
Fig. 2. U-37 was collected from the HPLC of a human lens ethanol extract. A: UV-spectrum of U-37 with Vmax 355, 260 nm. B: 3D £uores-
cence spectrum of U-37 with Ex345 nm/Em455 nm.
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b) and cleavage of the aromatic O-glucosidic linkage giving a
sodiated dehydro-disaccharide (fragment c). The calculated
m/z values for the proposed fragments are consistent with
those observed. These results were con¢rmed by additional
high-resolution tandem mass spectrometry experiments per-
formed in the negative mode. The parent ion at m/z 532.07
displayed fragmentation of the aromatic O-glucosidic linkage,
as was observed in positive ion mode. This yielded two intense
fragment ions corresponding to the two ‘halves’ of the com-
pound (Fig. 3B), i.e. the dehydro-disaccharide (fragment x)
and the UV ¢lter fragment 4-(2-amino-3-hydroxyphenyl)-4-
oxobutanoic acid (AHB) (fragment y). The measured masses
were consistent with the calculated m/z values for the pro-
posed fragments. These mass spectral data provide strong
evidence for the proposed structure (Fig. 3), with the two
hexose units present as a disaccharide attached to the phenolic
oxygen atom.
In order to investigate this further, U-37 was incubated
with 1 M HCl at 100‡C for either 10 min or 1 h. Following
removal of the acid, the samples were redissolved in H2O and
analysed by HPLC. Both hydrolysates displayed a major
peak, which co-eluted with an authentic standard of the ex-
pected aglucone AHB. Analysis of this peak by mass spec-
trometry revealed a protonated molecular ion at m/z 210, with
fragments at m/z 192 (H2O loss) and m/z 164 (formic acid
loss). These fragments were the same as those in the mass
spectrum of the authentic AHB.
Previous studies performed in our laboratory [2] and that of
others [7] have shown that L-glucosidase e¡ectively cleaves the
O-glucosidic linkage of 3OHKG and AHBG to form the cor-
responding aglucone moieties, 3OHKyn and AHB respec-
tively. Treatment of U-37 with L-glucosidase resulted in com-
plete conversion of U-37 to AHB. This result con¢rms that
the two C-6 sugars are glucose and that they are L-linked.
Quanti¢cation of the O-diglucoside was performed in indi-
vidual human lenses ranging in age from 16 to 93 years. As
shown in Fig. 4 the concentration of U-37 decreased linearly
in both the nucleus (r2 = 0.73, P6 0.0005, n = 50) and cortex
(r2 = 0.77, P6 0.0005, n = 50) as a function of age. Highest
levels were detected in lenses below the age of 20 years and
lowest levels were detected in lenses of 80 years of age or
older. No statistically signi¢cant di¡erence (Ps 0.01) was
found between the levels detected in the nuclear and cortical
regions of the lens.
4. Discussion
In this study we provide structural data on a novel UV ¢lter
compound found predominantly in younger human lenses.
This £uorophore shares absorbance and £uorescence similar-
ities with the major UV ¢lter compounds 3OHKG and
AHBG. High-resolution mass spectrometry demonstrated
that the unknown UV ¢lter compound is a disaccharide and
the L-glucosidase hydrolysis data indicated that both mono-
saccharides are glucose (L-linked). Since the UV ¢lter is
present at low levels in older lenses, and these are the ones
most readily obtained from Eye Banks, it was not possible to
purify su⁄cient quantities of the UV ¢lter compound for
analysis by nuclear magnetic resonance spectroscopy. It was
therefore not possible to determine unequivocally the position
of attachment between the two glucose residues. Extensive
examination of human lens extracts has shown no evidence
for the existence of a 3OHKyn-conjugated disaccharide com-
pound, thus, it appears unlikely that some 3OHKyn is diglu-
cosylated prior to deamination and reduction. We propose
Fig. 3. The proposed structure of U-37. A: The sodiated fragments
observed from the FTMS spectrum in the positive mode. B: The
fragments observed from the FTMS spectrum in the negative mode.
The observed and calculated m/z values for the fragments are listed
beneath the structures.
Fig. 4. The concentration of U-37 in human lenses as a function of
age. Linear regression lines shown, nucleus (r =30.85, P6 0.0005,
n = 50) and cortex (r =30.87, P6 0.0005, n = 50). b, nucleus; a,
cortex.
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that U-37 is formed via glucosylation of AHBG (Fig. 5). The
name of this UV ¢lter compound is 4-(2-amino-3-hydroxy-
phenyl)-4-oxobutanoic acid O-diglucoside (AHBDG).
As previously described for 3OHKG and AHBG, AHBDG
also contains an O-glucosidic link, which is a form of conju-
gation rarely encountered in mammals. Xanthurenic acid glu-
coside has recently been isolated from brunescent human
lenses [21] and is presumably derived from 3OHKG. Gluco-
sidic conjugation of the UV ¢lter compound 3OHKyn to form
3OHKG has long been attributed to UDP-glucosyl transfer-
ase [22]. Although the mechanism underlying the biosynthesis
of AHBDG has not been addressed here, it is likely that
UDP-glucosyl transferase is also responsible for transferring
the second glucose molecule to AHBG, resulting in the for-
mation of AHBDG. Glycosylation of systems similar to that
of AHBG are known to occur in plants [23], however, the
identi¢cation of this compound constitutes the only reported
disaccharide derivative to have been isolated from human
tissues.
One of the most common L-linked glucose systems observed
in nature is L(1C4) [24]. Cellobiose is the L(1C4)-linked
disaccharide of glucose (glucose-L-1C4-glucose), however,
cellobiose does not occur free in nature nor as a glucoside
[25]. Thus, we propose that the diglucoside component of
AHBDG is the L(1C6)-linked disaccharide of glucose, i.e.
L-gentiobiose (glucose-L-1C6-glucose). This disaccharide
has reportedly been found in plants joined to di¡erent aglu-
cones [23]. Enzymic hydrolysis by L-glucosidase of the pro-
posed gentiobioside of AHBDG would occur via initial hy-
drolysis of the gentiobiose into glucose and AHBG, followed
by removal of the aglucone group (AHB) [24].
A previous study has shown that the concentrations of both
3OHKG and AHBG decrease linearly with age [20]. In this
study, quanti¢cation of AHBDG also displayed a signi¢cant
decrease towards zero in both the nuclear and cortical regions
as a function of age. This is consistent with the observed
decrease in concentration of the proposed AHBDG metabolic
precursor (i.e. AHBG).
The discovery of this novel disaccharide represents the last
major UV ¢lter compound present in human lenses.
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